ER-xSmad6 blocks conditionally both aVBI and pVBI development
. | . | Ventral blood island phenotype, % embryos . | . | . | . | |||
---|---|---|---|---|---|---|---|---|
Injection site (n) . | Induced at stage 10.5 . | Normal VBI . | Anterior VBI only . | Posterior VBI only . | No VBI . | |||
Dorsal (11) | No | 100 | 0 | 0 | 0 | |||
Dorsal (16) | Yes | 13 | 0 | 56 | 31 | |||
Ventral (40) | No | 63 | 17 | 5 | 15 | |||
Ventral (30) | Yes | 27 | 67 | 6 | 0 |
. | . | Ventral blood island phenotype, % embryos . | . | . | . | |||
---|---|---|---|---|---|---|---|---|
Injection site (n) . | Induced at stage 10.5 . | Normal VBI . | Anterior VBI only . | Posterior VBI only . | No VBI . | |||
Dorsal (11) | No | 100 | 0 | 0 | 0 | |||
Dorsal (16) | Yes | 13 | 0 | 56 | 31 | |||
Ventral (40) | No | 63 | 17 | 5 | 15 | |||
Ventral (30) | Yes | 27 | 67 | 6 | 0 |
Embryos were injected with ER-xSmad6 mRNA at the 4-cell stage into either the 2 presumptive dorsal or ventral blastomeres (n = number of embryos) and either cultured alone or induced at stage 10.5 with E2. Some leakiness of the fusion protein is evident in the ventral-targeted injections cultured in the absence of E2, but there is a clear trend toward blocking of either anterior or posterior domains by activated ER-xSmad6.